Halozyme Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.

CEO

Helen I. Torley

CEOHelen I. Torley

Employees

373

Employees373

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

373

Employees373

HALO Key Statistics

Market cap

5.06B

Market cap5.06B

Price-Earnings ratio

18.73

Price-Earnings ratio18.73

Dividend yield

—

Dividend yield—

Average volume

767.85K

Average volume767.85K

High today

$40.41

High today$40.41

Low today

$38.88

Low today$38.88

Open price

$39.56

Open price$39.56

Volume

820.13K

Volume820.13K

52 Week high

$45.00

52 Week high$45.00

52 Week low

$29.85

52 Week low$29.85

HALO News

Investor's Business Daily 2d

Halozyme Therapeutics Shows Rising Relative Price Performance; Still Shy Of Key Benchmark - Investor's Business Daily

In a welcome move, Halozyme Therapeutics (HALO) saw its Relative Strength Rating improve from 69 to 72 on Wednesday. X IBD's proprietary rating tracks share pr...

Simply Wall St 6d

Is Halozyme Therapeutics Using Too Much Debt? - Simply Wall St

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about......

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell